Notes:
Volume 6, Issue 4 (Suppl)
Clin Pharmacol Biopharm, an open access journal
ISSN: 2167-065X
Page 21
Euro Biopharma & Ethnopharmacology 2017
November 09-11, 2017
&
6
th
International Conference and Exhibition on
November 09-11, 2017 Vienna, Austria
4
th
EUROPEAN BIOPHARMA CONGRESS
PHARMACOLOGY AND ETHNOPHARMACOLOGY
Joint Event
AReview of ethnopharmacological research of some cameroonian medicinal plants
1*
Ngono Ngane R A,
2
Moukeu R S
and
3
Tchinda Tiabou A
1
Laboratory of Phytobiochemistry, University of Douala, Cameroon
2
University of Douala, Cameroon
3
Laboratory of Phytochemistry, Centre for Studies on Medicinal Plants and Traditional Medicine, Institute of Medical Research and Medicinal Plants Studies (IMPM),
Cameroon
T
he use of herbal medicines as complements or alternatives to modern medicines has been on the increase. This review summarizes
research carried out on some Cameroonian medicinal plants between 2007 and 2017 by our research team at the Faculty of
Science of the University of Douala in collaboration with some national and international scientists. Medicinal plants are resources of
traditional medicines and modern medicine derived from plants. This study was designed to outline some biologic activities of various
medicinal plants extracts used by the Cameroonians’ and central African people. Several medicinal plants growing in Cameroon were
identified as having pharmacological properties. These plants species which include
Crassocephalum bauchiense, Dichaentanthera
africana, Harungana madagascariensis, Milletia conraui, Nauclea latifolia, Pecedanum zenkeri, Ptelopsis hylodendron, Schefflera
barteri, Strychnos icaja, Strychnos malacoclados
with healing properties are listed alongside their traditional use and a summary of
the scientific research achieved are given. They were tested for their in vitro or
in vivo
biological activity by standard protocols. These
ten plants have shown antimicrobial, antioxidant, antiplasmodial, immunomodulatory, analgesic, antipyretic, anti-Herpes simplex
virus and α-glucosidase inhibitory activities. Natural products (diterpenoids, alkaloids and flavone) have been identified from five of
them. The results suggest that the plants extracts could be a promising rough material for the development of new and more effective
modern drugs. Based on these results, drugs from Crassocephalum were developed but no patent is obtained till today.
angono@yahoo.comNgono Ngane R A et al., Clin Pharmacol Biopharm 2017, 6:4(Suppl)
DOI: 10.4172/2167-065X-C1-025